Literature DB >> 2714976

Nocturnal plasma melatonin levels in migraine: a preliminary report.

B Claustrat, C Loisy, J Brun, S Beorchia, J L Arnaud, G Chazot.   

Abstract

We determined by radioimmunoassay plasma melatonin levels on blood samples drawn at 11 p.m. in migraine patients and control subjects. Ninety-three cephalalgic outpatients (75 females, 18 males) were compared to a control group (24 females, 22 males) matched according to age. Patients were divided into subgroups presenting common migraine (n = 38); ophthalmic migraine (n = 12); and tension headache associated with ophthalmic or common migraine (n = 24), and associated depressive status (n = 19). Statistical analysis revealed a decrease in plasma melatonin levels for the entire migraine population, compared to the control one, and a heterogeneity in both controls and patients; this heterogeneity was found mainly in the depressive and tension headache subgroups. When the migraine population--from which the depressive patients were excluded--was divided into male and female subgroups, a decrease in plasma melatonin levels was observed only for the female subgroups. Results are discussed with reference to the role of the pineal gland in the synchronization of the organism with the environmental conditions.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2714976     DOI: 10.1111/j.1526-4610.1989.hed22904242.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  19 in total

1.  Melatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment.

Authors:  Rüdiger Hardeland
Journal:  Aging Dis       Date:  2011-02-10       Impact factor: 6.745

2.  Is migraine a lateralization defect?

Authors:  Jani Kaaro; Timo Partonen; Paulami Naik; Nouchine Hadjikhani
Journal:  Neuroreport       Date:  2008-08-27       Impact factor: 1.837

Review 3.  Role of melatonin in the pathophysiology of migraine: implications for treatment.

Authors:  Barbara Vogler; Alan M Rapoport; Stewart J Tepper; Fred Sheftell; Marcelo E Bigal
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

4.  Can Circadian Dysregulation Exacerbate Migraines?

Authors:  Jason C Ong; Hannah L Taylor; Margaret Park; Helen J Burgess; Rina S Fox; Sarah Snyder; Jeanetta C Rains; Colin A Espie; James K Wyatt
Journal:  Headache       Date:  2018-05-04       Impact factor: 5.887

5.  Pharmacokinetics of melatonin in man after intravenous infusion and bolus injection.

Authors:  C Mallo; R Zaĭdan; G Galy; E Vermeulen; J Brun; G Chazot; B Claustrat
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

6.  Low urinary 6-sulphatoxymelatonin concentrations in acute migraine.

Authors:  Marcelo Rodrigues Masruha; Domingos Sávio de Souza Vieira; Thais Soares Cianciarullo Minett; José Cipolla-Neto; Eliova Zukerman; Luiz Celso Pereira Vilanova; Mario Fernando Prieto Peres
Journal:  J Headache Pain       Date:  2008-07-02       Impact factor: 7.277

7.  Melatonin 4 mg as prophylactic therapy for primary headaches: a pilot study.

Authors:  Anastasia Bougea; Nikolaos Spantideas; Vasilis Lyras; Theodoros Avramidis; Thomas Thomaidis
Journal:  Funct Neurol       Date:  2016 Jan-Mar

Review 8.  Sleep and headache.

Authors:  K C Brennan; Andrew Charles
Journal:  Semin Neurol       Date:  2009-09-09       Impact factor: 3.420

9.  Chronobiology of Melatonin beyond the Feedback to the Suprachiasmatic Nucleus-Consequences to Melatonin Dysfunction.

Authors:  Rüdiger Hardeland
Journal:  Int J Mol Sci       Date:  2013-03-12       Impact factor: 5.923

10.  Clinical relevance of depressed kynurenine pathway in episodic migraine patients: potential prognostic markers in the peripheral plasma during the interictal period.

Authors:  Bernadett Tuka; Aliz Nyári; Edina Katalin Cseh; Tamás Körtési; Dániel Veréb; Ferenc Tömösi; Gábor Kecskeméti; Tamás Janáky; János Tajti; László Vécsei
Journal:  J Headache Pain       Date:  2021-06-25       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.